Trazodone, a phenylpiperazine–triazolopyridine antidepressant, was originally discovered and developed in Italy in the 1970s by Angelini research laboratories. Trazodone is used to treat depression and to treat the combination of symptoms of anxiety and depression. Like most antidepressants, trazodone has also been used in limited numbers of patients to treat panic disorder, obsessive-compulsive disorder, attention-deficit/hyperactivity disorder, enuresis (bed-wetting), eating disorders such as bulimia nervosa, cocaine dependency, and the depressive phase of bipolar (manic-depressive) disorder. It should be noted, however, that trazodone has not received official approval from the United States Food and Drug Administration (FDA) for these secondary uses.
Only few manufacturers can produce trazodone hydrochloride (API) in USA. Teva, the Israeli company, has a production base in the United States, dominates the market with the production market share of 92.98% in 2015
Market Analysis and Insights: Global Trazodone Hydrochloride (API) Market
The global Trazodone Hydrochloride (API) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Trazodone Hydrochloride (API) Scope and Market Size
The global Trazodone Hydrochloride (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Trazodone Hydrochloride (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Trazodone Hydrochloride (API)
Others
Segment by Application
Antidepression
Anxiolytic
Hypnotic
Others
The Trazodone Hydrochloride (API) market is analysed and market size information is provided by regions (countries). Segment by Application, the Trazodone Hydrochloride (API) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Angelini
Mylan
Fermion
The Piramal Group
Only few manufacturers can produce trazodone hydrochloride (API) in USA. Teva, the Israeli company, has a production base in the United States, dominates the market with the production market share of 92.98% in 2015
Market Analysis and Insights: Global Trazodone Hydrochloride (API) Market
The global Trazodone Hydrochloride (API) market was valued at US$ XX in 2020 and will reach US$ XX million by the end of 2027, growing at a CAGR of XX% during 2022-2027.
Global Trazodone Hydrochloride (API) Scope and Market Size
The global Trazodone Hydrochloride (API) market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Trazodone Hydrochloride (API) market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2016-2027.
Segment by Type
Trazodone Hydrochloride (API)
Others
Segment by Application
Antidepression
Anxiolytic
Hypnotic
Others
The Trazodone Hydrochloride (API) market is analysed and market size information is provided by regions (countries). Segment by Application, the Trazodone Hydrochloride (API) market is segmented into North America, Europe, China, Japan, Southeast Asia, India and Other Regions.
By Company
Teva
Angelini
Mylan
Fermion
The Piramal Group
Frequently Asked Questions
This market study covers the global and regional market with an in-depth analysis of the overall growth prospects in the market. Furthermore, it sheds light on the comprehensive competitive landscape of the global market. The report further offers a dashboard overview of leading companies encompassing their successful marketing strategies, market contribution, recent developments in both historic and present contexts.
- By product type
- By End User/Applications
- By Technology
- By Region
The report provides a detailed evaluation of the market by highlighting information on different aspects which include drivers, restraints, opportunities, and threats. This information can help stakeholders to make appropriate decisions before investing.